KimJThayabaranathanTDonnanGA, et alGlobal stroke statistics 2019. Int J Stroke2020; 15: 819–838.
2.
MalikRChauhanGTraylorM, et alMultiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet2018; 50: 524–537.
3.
LindgrenAGBraunRGJuhl MajersikJ, et alInternational Stroke Genetics Consortium recommendations for studies of genetics of stroke outcome and recovery. Int J Stroke2022; 17: 260–268.
4.
JanssenHBernhardtJCollierJM, et alAn enriched environment improves sensorimotor function post-ischemic stroke. Neurorehabil Neural Repair2010; 24: 802–813.
5.
JanssenHAdaLMiddletonS, et alAltering the rehabilitation environment to improve stroke survivor activity: a Phase II trial. Int J Stroke2022; 17: 299–307.
6.
MeadGELeggLTilneyR, et alFluoxetine for stroke recovery: meta-analysis of randomized controlled trials. Int J Stroke2020; 15: 365–376.
7.
WardNSBranderFKellyK. Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme. J Neurol Neurosurg Psychiatry2019; 90: 498–506.
8.
JohnstoneABranderFKellyK, et alDifferences in outcomes following an intensive upper-limb rehabilitation program for patients with common central nervous system-acting drug prescriptions. Int J Stroke2022; 17: 269–281.